Waki, Yuhei
Irino, Tomoyuki
Makuuchi, Rie
Notsu, Akifumi
Kamiya, Satoshi
Tanizawa, Yutaka
Bando, Etsuro
Kawamura, Taiichi
Terashima, Masanori
Article History
First Online: 3 September 2019
Compliance with ethical standards
:
: Masanori Terashima has received personal fees from Taiho, Chugai, Ono, Bristol-Myers Squibb, Yakult, Takeda, Eli Lilly, Pfizer, and Daiichi Sankyo, outside the submitted work. All other authors declare no conflict of interest.
: This study was approved by the institutional review board of Shizuoka Cancer Center (approval no. 29-J163-29-1-3).
: Informed consent was not obtained from the patients. Instead, all patients were previously informed of an opt-out method.